| H2AX: A key player in DNA damage response and a promising target for cancer therapy KS Prabhu, S Kuttikrishnan, N Ahmad, U Habeeba, Z Mariyam, ... Biomedicine & Pharmacotherapy 175, 116663, 2024 | | 2024 |
| Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans KS Prabhu, F Ahmad, S Kuttikrishnan, R Leo, TA Ali, M Izadi, JM Mateo, ... Cell Death Discovery 10 (1), 225, 2024 | | 2024 |
| Anticancer Potential and Molecular Targets of Pristimerin in Human Malignancies KS Prabhu, S Jessy, S Kuttikrishnan, F Mujeeb, Z Mariyam, U Habeeba, ... Pharmaceuticals 17 (5), 578, 2024 | | 2024 |
| Plasma neurological biomarkers as a measure of neurotoxicity in pediatric dental general anesthesia: a prospective observational feasibility study S Chakithandy, H Nazzal, M Matoug-Elwerfelli, S Narasimhan, S Uddin, ... European Archives of Paediatric Dentistry, 1-9, 2024 | | 2024 |
| Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer A Khan, Y Waheed, S Kuttikrishnan, KS Prabhu, T El-Elimat, S Uddin, ... Frontiers in Pharmacology 15, 1352907, 2024 | | 2024 |
| Signaling networks guiding erythropoiesis S Kuttikrishnan, KS Prabhu, AQ Khan, S Uddin Current Opinion in Hematology, 10.1097, 2024 | | 2024 |
| Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model S Kuttikrishnan, M Hasan, KS Prabhu, T El-Elimat, NH Oberlies, ... Experimental Cell Research 435 (1), 113907, 2024 | | 2024 |
| Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT/SKP2 signaling pathway S Kuttikrishnan, F Ahmad, JM Mateo, KS Prabhu, T El‐Elimat, ... Cell Biology International 48 (2), 190-200, 2024 | 2 | 2024 |
| Beyond Genetics: Exploring the Role of Epigenetic Alterations in Breast Cancer KS Prabhu, HQ Sadida, S Kuttikrishnan, K Junejo, AA Bhat, S Uddin Pathology-Research and Practice, 155174, 2024 | 2 | 2024 |
| Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment Q Fernandes, G Sher, KS Prabhu, S Kuttikrishnan, M Merhi, S Dermime, ... Discovery Medicine 36 (180), 1-15, 2024 | | 2024 |
| In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway S Kuttikrishnan, T Masoodi, F Ahmad, G Sher, KS Prabhu, JM Mateo, ... Journal of Dermatological Science 112 (2), 83-91, 2023 | 1 | 2023 |
| Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology AV Singh, V Chandrasekar, N Paudel, P Laux, A Luch, D Gemmati, ... Biomedicine & Pharmacotherapy 163, 114784, 2023 | 56 | 2023 |
| Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression A Raza, R Mohsen, A Kanbour, AR Zar Gul, A Philip, S Vijayakumar, ... Frontiers in Immunology 14, 1157100, 2023 | 3 | 2023 |
| Corrigendum: Curcumin-mediated degradation of S-phase kinase protein 2 induces cytotoxic effects in human papillomavirus-positive and negative squamous carcinoma cells AQ Khan, KS Siveen, KS Prabhu, S Kuttikrishnan, S Akhtar, A Shaar, ... Frontiers in Oncology 13, 2023 | | 2023 |
| Guggulsterone induces apoptosis in multiple myeloma cells by targeting high mobility group box 1 via janus activated kinase/signal transducer and activator of transcription pathway S Akhtar, L Zarif, S Kuttikrishnan, KS Prabhu, K Patil, S Nisar, ... Cancers 14 (22), 5621, 2022 | 5 | 2022 |
| Natural products as chemo-radiation therapy sensitizers in cancers S Nisar, T Masoodi, KS Prabhu, S Kuttikrishnan, L Zarif, S Khatoon, S Ali, ... Biomedicine & Pharmacotherapy 154, 113610, 2022 | 29 | 2022 |
| Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications G Sher, NA Salman, AQ Khan, KS Prabhu, A Raza, M Kulinski, ... Seminars in cancer biology 83, 152-165, 2022 | 63 | 2022 |
| Natural resorcylic acid lactones: A chemical biology approach for anticancer activity K Shilpa, KS Prabhu, AH Al Sharie, A Zu'bi, O Yazan, FQ Alali, ... Elsevier, 2022 | | 2022 |
| Natural resorcylic acid lactones: A chemical biology approach for anticancer activity S Kuttikrishnan, KS Prabhu, AH Al Sharie, YO Al Zu'bi, FQ Alali, ... Drug Discovery Today 27 (2), 547-557, 2022 | 20 | 2022 |
| The incidence and determinants of metabolic syndrome amongst a group of migrants to qatar: A prospective longitudinal observational cohort study 24-months post-migration RM Al-Adawi, KS Prabhu, D Stewart, C Ryan, H Abdelaziz, M Eledrisi, ... Journal of Clinical Medicine 11 (1), 34, 2021 | 5 | 2021 |
Shahab Uddin, PhDPrincipal Research Scientist & Professor of Cancer Biology Hamad Medical Corporation在 hamad.qa 的电子邮件经过验证
